Services
Press Release Distribution
Key Features
Optimize Media Write-ups
Guaranteed News Posting
Intelligence Reports
Empower SEO and Social Media
Generate Business Leads
Unlimited Trade Categories
Distribution Network
Success Stories
Cloud Comrade
Creative Consulting Group
CUHK Business School
De Beers Group
Evolution Wellness
Michael Page
SleekFlow
Spackman Entertainment Group
Newsroom
Journalists
Our Story
About Us
CSR
PR Insights
Contact Us
Careers
EN
简体
繁體
VN
IND
CONTACT US
English
简体
繁體
Việtnam
Bahasa Indonesia
Services
Press Release Distribution
Key Features
Optimize Media Write-ups
Guaranteed News Posting
Intelligence Reports
Empower SEO and Social Media
Generate Business Leads
Unlimited Trade Categories
Distribution Network
Success Stories
Cloud Comrade
Creative Consulting Group
CUHK Business School
De Beers Group
Evolution Wellness
Michael Page
SleekFlow
Spackman Entertainment Group
Newsroom
(current)
Journalists
(current)
Our Story
About Us
CSR
PR Insights
(current)
Contact Us
(current)
Careers
(current)
Back to Newsroom
News from Abivax
#Business
14 May 2020
Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
#Business
14 May 2020
Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
Talk to Media OutReach Newswire today
CONTACT US NOW